Charles R. Goulding and Kate Esposito consider how the Chan Zuckerberg Initiative is revolutionizing biotechnology through low-cost 3D bioprinting and advanced cellular research across its three pioneering Biohubs.
volumetric biotechnologies
3D Systems To 3D Print Human Organs After Major Acquisition
3D Systems announced the acquisition of Volumetric Biotechnologies, solidifying their healthcare strategy.
